APA (7th ed.) Citation

C, B., S, P., J, L., EP, H., ES, K., GA, B., . . . GJ, G. (2021). Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M1 -acetylcholine receptor agonist: A randomized cross-over trial. British journal of clinical pharmacology, 87(11), 4439. https://doi.org/10.1111/bcp.14872

Chicago Style (17th ed.) Citation

C, Bakker, et al. "Safety, Pharmacokinetics and Pharmacodynamics of HTL0009936, a Selective Muscarinic M1 -acetylcholine Receptor Agonist: A Randomized Cross-over Trial." British Journal of Clinical Pharmacology 87, no. 11 (2021): 4439. https://doi.org/10.1111/bcp.14872.

MLA (9th ed.) Citation

C, Bakker, et al. "Safety, Pharmacokinetics and Pharmacodynamics of HTL0009936, a Selective Muscarinic M1 -acetylcholine Receptor Agonist: A Randomized Cross-over Trial." British Journal of Clinical Pharmacology, vol. 87, no. 11, 2021, p. 4439, https://doi.org/10.1111/bcp.14872.